Reprogramming CAR T-Cells with designed bioPROTACs
Vivek S. Peche, Sebastian Kenny, Tae Gun Kang, Brian Coventry, Tian Mi, Inna Goreshnik, Mariana Garcia Sanchez, Reid Martin, Macey Smith, Dionne K. Vafeados, Rahul S. Kathayat, Kaiwen Yu, Zuo-Fei Yuan, Long Wu, Anthony A. High, , Stephen M Gottschalk
This paper demonstrates that bioPROTACs can reprogram CAR T-cells by targeting DNMT3A, offering a tunable alternative to gene editing for enhancing T-cell function.
bioRxiv · Feb 22, 2026 · PreprintImmunology